Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
ReST THERAPEUTICS logo — Recovery from Stress and Trauma

ReST THERAPEUTICS

Recovery from Stress and Trauma

Founded 2020 United States New Haven, United States 8 employees Grant Biotechnology, Pharmaceutical

General Information

Company Name ReST THERAPEUTICS
Founded Year 2020
Location United States New Haven, United States +2
Employees 8
Industries Biotechnology, Pharmaceutical
Funding Stage Grant
Social

Get notified when ReST THERAPEUTICS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ReST THERAPEUTICS

ReST Therapeutics is developing transformative therapies for patients with significant unmet needs in Psychiatry and Neurodegeneration. Our lead program, RST-01, will disrupt the existing PTSD treatment paradigm, focusing on early intervention in the aftermath of a traumatic event and a patient-centric clinical strategy. RST-01 targets specific NMDA receptors sub-types, critical to memory consolidation. Pre-clinical testing has shown drastic reductions in fear, anxiety and depression, as well as the restoration of cognitive function. Finally, reduced neuroinflammation in neurodegenerative models paves the way for an extended development portfolio focusing on restoring the quality of lives of those affected by these debilitating diseases.

Taxonomy: Pharmaceutical development, PTSD treatment, Neuropsychiatry, Neuroinflammation, Neurodegeneration, Clinical trials, NMDA receptor modulation, Therapeutics, Pre-clinical testing, Cognitive function restoration, Memory consolidation, Seed funding, Non-clinical testing

No funding data available for ReST THERAPEUTICS yet.

Get notified when ReST THERAPEUTICS raises funding

ReST THERAPEUTICS Alternatives & Competitors

ReST THERAPEUTICS vs
Xagenic
Xagenic

Empowering clinicians with rapid, near-patient molecular testing for improved patient care and reduc...

Series B
Biotechnology, Health Care
ReST THERAPEUTICS vs
Respiratory Motion
Respiratory Motion

Providing early warning of respiratory collapse across diverse patient populations and medical envir...

Series D
11-50 employees
Biotechnology, Health Care
ReST THERAPEUTICS vs
VelaLabs
VelaLabs Austria

Contract laboratory for Pharma & Biotech - non clinical & clinical lab analysis for biologics, chemi...

58 employees
Biotechnology

FAQ About ReST THERAPEUTICS

Recovery from Stress and Trauma
ReST THERAPEUTICS was founded in 2020.
ReST THERAPEUTICS is headquartered in New Haven, United States.
ReST THERAPEUTICS operates in the following industries: Biotechnology, Pharmaceutical.
ReST THERAPEUTICS has approximately 8 employees.
Top alternatives and competitors to ReST THERAPEUTICS include Xagenic, Respiratory Motion, VelaLabs, Velabs Therapeutics, SteriLogix™. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ReST THERAPEUTICS and Xagenic are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ReST THERAPEUTICS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy